Dr Lal PathLabs chases deals in ‘tough-to-crack’ south India

Dr Lal PathLabs, India's largest diagnostics company, plans to double its volume growth and close deals in southern India by the end of the financial year 2025. The company is looking to acquire small and mid-sized diagnostic companies in states like Tamil Nadu, Karnataka, and Andhra Pradesh. It also plans to expand its presence in tier-II and smaller cities in the northern and eastern regions of India. Additionally, Dr Lal PathLabs aims to set up 20 new labs in key cities and build hub labs in smaller towns. The company's focus on acquisitions and organic growth is driven by its surplus cash of nearly ₹1,000 crore.